2.58
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Entasis Therapeutics Holdings Inc | ETTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.20 | 8.4% | 2.58 | 2.34 | 2.64 | 2.34 | 2.38 | 18:00:07 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.25 | 2.81 | 0.56 | 19.93% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 226 | 34,455 | $ 2.48 | $ 85,348 | 24,020 | 1.75 - 9.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 3,228 | $ 2.58 | USD |
Entasis Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 37.70M | 14.61M | 14.59M | $ 7.00M | $ - | -3.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 0.20% |
Entasis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ETTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.62 | 2.70 | 2.31 | 2.39 | 25,687 | -0.04 | -1.53% |
| 1 Month | 2.72 | 2.80 | 2.31 | 2.62 | 21,868 | -0.14 | -5.15% |
| 3 Months | 5.25 | 5.64 | 1.75 | 2.89 | 31,482 | -2.67 | -50.86% |
| 6 Months | 4.70 | 5.64 | 1.75 | 3.43 | 20,329 | -2.12 | -45.11% |
| 1 Year | 6.24 | 9.25 | 1.75 | 4.59 | 16,638 | -3.66 | -58.65% |
| 3 Years | 13.45 | 13.70 | 1.75 | 6.90 | 28,857 | -10.87 | -80.82% |
| 5 Years | 13.45 | 13.70 | 1.75 | 6.90 | 28,857 | -10.87 | -80.82% |
Entasis Therapeutics Description
| Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes Zoliflodacin, ETX0282CPDP, and NBP program. |
